150 related articles for article (PubMed ID: 16458967)
21. Factors Affecting Glaucoma Medication Adherence and Interventions to Improve Adherence: A Narrative Review.
Moore SG; Richter G; Modjtahedi BS
Ophthalmol Ther; 2023 Dec; 12(6):2863-2880. PubMed ID: 37698824
[TBL] [Abstract][Full Text] [Related]
22. Adherence and Persistence to Medical Therapy in Glaucoma: An Overview.
Quaranta L; Novella A; Tettamanti M; Pasina L; Weinreb RN; Nobili A
Ophthalmol Ther; 2023 Oct; 12(5):2227-2240. PubMed ID: 37311908
[TBL] [Abstract][Full Text] [Related]
23. Fixed versus Unfixed Combination of Topical Latanoprost/Timolol for Glaucoma: An Observational Study Investigating the Level of Adherence and Ocular Surface Health.
Toumanidou V; Diafas A; Georgiadis N; Tsinopoulos I
J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176579
[TBL] [Abstract][Full Text] [Related]
24. Reduction of Eyedrop Volume for Topical Ophthalmic Medications with the Nanodropper Bottle Adaptor.
St Peter DM; Steger JS; Patnaik JL; Davis N; Kahook MY; Seibold LK
Med Devices (Auckl); 2023; 16():71-79. PubMed ID: 37056302
[TBL] [Abstract][Full Text] [Related]
25. Cost-Utility Analysis of a Medication Adherence-Enhancing Educational Intervention for Glaucoma.
Hung A; Williams AM; Newman-Casey PA; Muir KW; Gatwood J
Ophthalmol Glaucoma; 2023; 6(4):395-404. PubMed ID: 36707031
[TBL] [Abstract][Full Text] [Related]
26. Real-world data from selective laser trabeculoplasty in Brazil.
Abe RY; Maestrini HA; Guedes GB; Nascimento MM; Iguma CI; de Miranda Santos HD; Nasr MG; Lucena-Junior RP; Prata TS
Sci Rep; 2022 Feb; 12(1):1923. PubMed ID: 35121762
[TBL] [Abstract][Full Text] [Related]
27. Comparing the effectiveness of different postoperative counseling methods for post-keratoplasty patients.
Anitha V; Nair S; Ravindran M; Uduman MS
Indian J Ophthalmol; 2022 Feb; 70(2):517-522. PubMed ID: 35086229
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Medication Adherence Assessment Tools to Identify Glaucoma Medication Nonadherence.
Cho J; Niziol LM; Lee PP; Heisler M; Resnicow K; Musch DC; Newman-Casey PA
Ophthalmol Glaucoma; 2022; 5(2):137-145. PubMed ID: 34358735
[TBL] [Abstract][Full Text] [Related]
29. Comparison of BAK-preserved latanoprost and polyquad-preserved travoprost on ocular surface parameters in patients with glaucoma and ocular hypertension.
Muz OE; Dagdelen K; Pirdal T; Guler M
Int Ophthalmol; 2021 Nov; 41(11):3825-3835. PubMed ID: 34263385
[TBL] [Abstract][Full Text] [Related]
30. Impact of pharmacist-led interventions in improving adherence to glaucoma medications in the geriatric population.
Aleem A; Amin F; Asim MH; Farooq N; Arshad S; Raziq M
Eur J Hosp Pharm; 2021 Nov; 28(Suppl 2):e191-e196. PubMed ID: 34233905
[TBL] [Abstract][Full Text] [Related]
31. Retinal Ganglion Cell Transplantation: Approaches for Overcoming Challenges to Functional Integration.
Zhang KY; Aguzzi EA; Johnson TV
Cells; 2021 Jun; 10(6):. PubMed ID: 34200991
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of microinvasive glaucoma surgery with cataract extraction in patients with normal-tension glaucoma.
Chang EK; Gupta S; Chachanidze M; Hall N; Chang TC; Solá-Del Valle D
Sci Rep; 2021 Apr; 11(1):8910. PubMed ID: 33903701
[TBL] [Abstract][Full Text] [Related]
33. Review of glaucoma medication adherence monitoring in the digital health era.
Erras A; Shahrvini B; Weinreb RN; Baxter SL
Br J Ophthalmol; 2023 Feb; 107(2):153-159. PubMed ID: 33858837
[TBL] [Abstract][Full Text] [Related]
34. Sustained-release drug delivery systems for the treatment of glaucoma.
Kesav NP; Young CEC; Ertel MK; Seibold LK; Kahook MY
Int J Ophthalmol; 2021; 14(1):148-159. PubMed ID: 33469497
[TBL] [Abstract][Full Text] [Related]
35. Decreasing Avoidable Vision Loss: Identifying Antecedents of Adherence.
Morse AR; Seiple WH
Clin Ophthalmol; 2020; 14():3735-3739. PubMed ID: 33173271
[TBL] [Abstract][Full Text] [Related]
36. Signs and Symptoms of Ocular Surface Disease: The Reasons for Patient Dissatisfaction with Glaucoma Treatments.
Stalmans I; Lemij H; Clarke J; Baudouin C;
Clin Ophthalmol; 2020; 14():3675-3680. PubMed ID: 33162751
[TBL] [Abstract][Full Text] [Related]
37. Factors Associated With Favorable Laser Trabeculoplasty Response: IRIS Registry Analysis.
Chang TC; Parrish RK; Fujino D; Kelly SP; Vanner EA
Am J Ophthalmol; 2021 Mar; 223():149-158. PubMed ID: 33049242
[TBL] [Abstract][Full Text] [Related]
38. Reasons for the Underutilization of Generic Drugs by US Ophthalmologists: A Survey.
Dietze J; Priluck A; High R; Havens S
Ophthalmol Ther; 2020 Dec; 9(4):955-970. PubMed ID: 32813159
[TBL] [Abstract][Full Text] [Related]
39. Current Medical Therapy and Future Trends in the Management of Glaucoma Treatment.
Cvenkel B; Kolko M
J Ophthalmol; 2020; 2020():6138132. PubMed ID: 32774906
[TBL] [Abstract][Full Text] [Related]
40. Predicting Adherence With the Glaucoma Treatment Compliance Assessment Tool.
Sanchez FG; Mansberger SL; Newman-Casey PA
J Glaucoma; 2020 Nov; 29(11):1017-1024. PubMed ID: 32740508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
